Your search history is turned on.
Date: March 8, 2019 Jurisdictions: Alberta, British Columbia, Ontario
FORM 51-102F3 MATERIAL CHANGE REPORT Item 1 Name and Address of Company Delivra Corp. (Delivra or the Company) 347 Grays Road Hamilton, Ontario L8E 2Z1 Item 2 Date of Material Change March 3, 2019 Item 3 News Release On March 4, 2019, Harvest One Cannabis Inc. (H1) and the Company issued a join...
Date: March 5, 2019 Jurisdictions: Alberta, British Columbia, Ontario
HARVEST ONE CANNABIS INC. and DELIVRA CORP. ARRANGEMENT AGREEMENT Dated as of March 3, 2019 TABLE OF CONTENTS Page -i- ARTICLE 1 DEFINITIONS, INTERPRETATION AND SCHEDULES.............................. 2 1.1 Definitions....................................................................
Date: March 4, 2019 Jurisdictions: Alberta, British Columbia, Ontario
HARVEST ONE ACQUIRES DELIVRA TO STRENGTHEN ITS MEDICAL AND WELLNESS DIVISION March 4, 2019 Toronto, Ontario Harvest One Cannabis Inc. (TSXV: HVT, OTCQX: HRVOF Harvest One) and Delivra Corp. (TSXV: DVA Delivra) are pleased to announce today that they have entered into a definitive arrangement agreement (the Arrangement Agreement) pu...
Date: February 6, 2019 Jurisdictions: Alberta, British Columbia, Ontario
DELIVRA PUBLISHES POSITIVE RESULTS UTILIZING ITS UNIQUE PLATFORM TECHNOLOGY FOR TOPICAL DOXYCYCLINE February 6, 2019 - Toronto, Ontario Delivra Corp. (TSXV: DVA - Delivra or the Company) today announced the publication of positive data from a laboratory and clinical study demonstrating the stability, safety and efficacy to treat diabetic wounds, using Delivras platf...
Date: January 8, 2019 Jurisdictions: Alberta, British Columbia, Ontario
DELIVRA PUBLISHES POSITIVE RESULTS UTILIZING ITS NOVEL PLATFORM TECHNOLOGY FOR VARICOSE VEINS January 8, 2019 - Toronto, Ontario Delivra Corp. (TSXV: DVA - Delivra or the Company) today announced the publication of positive data from a clinical study demonstrating the safety and efficacy to treat chronic venous insufficiency of lower limbs, using the LivReliefTM Var...
Date: December 11, 2018 Jurisdictions: Alberta, British Columbia, Ontario
DELIVRA PUBLISHES POSITIVE RESULTS USING ITS PLATFORM TECHNOLOGY FOR TOPICAL ADVILTM (IBUPROFEN) AND CELEBREXTM (CELECOXIB) December 11, 2018 - Toronto, Ontario Delivra Corp. (TSXV: DVA - Delivra or the Company) today announced the publication of positive data from a pre-clinical study demonstrating the safety and efficacy to treat pain directly with a topical ve...
Date: November 19, 2018 Jurisdictions: Alberta, British Columbia, Ontario
DELIVRA ACHIEVES RECORD THIRD QUARTER 2018 REVENUES November 19, 2018 - Toronto, Ontario Delivra Corp. (TSXV: DVA - Delivra or the Company) reported its financial results for the three and nine months ended September 30, 2018. All figures are reported in Canadian dollars ($), unless otherwise indicated. Delivras financial statements are prepared in accordance wit...
Microsoft Word - DVA-Q3CFO-Sep30-2018 FORM52109FV2 CERTIFICATIONOFINTERIMFILINGS VENTUREISSUERBASICCERTIFICATE I,Mr.PascalAttard,ChiefFinancialOfficerofDelivraCorp.,certifythefollowing: 1. Review:IhavereviewedtheinterimfinancialreportandinterimMD&A(together,theinterimfilings)of DelivraCorp.(theissuer)forthe...
Microsoft Word - DVA-Q3CEO-Sep30-2018 FORM52109FV2 CERTIFICATIONOFINTERIMFILINGS VENTUREISSUERBASICCERTIFICATE I,Dr.JosephGabriele,ChiefExecutiveOfficerofDelivraCorp.,certifythefollowing: 1. Review:IhavereviewedtheinterimfinancialreportandinterimMD&A(together,theinterimfilings)of DelivraCorp.(theissuer)forth...
Delivra Corp. Management Discussion & Analysis For the three and nine months ended September 30, 2018 Delivra Corp. - Management Discussion & Analysis For the three and nine months ended September 30, 2018 2 ...